January 30, 2026- McKesson Corporation announced that it has closed the transaction to sell its retail and distribution businesses in Norway to NorgesGruppen, a privately owned retail group. McKesson announced on August 4, 2025, that it planned to divest Norway, included within the Other segment. The transaction represents the final step in McKesson’s commitment to fully exit its European operations.
This transaction will enable McKesson to focus strategy and capital allocation on expanding and accelerating its growth platforms within Oncology and Multispecialty and Biopharma Services.
Additional details related to the divestiture will be provided on the Company’s Fiscal Third Quarter Earnings call, Wednesday, February 4, 2026, and on the company’s Investor Relations website.